Form PTO/SB/30 Request for Continued Examination (RCE) Transmittal

Doc Code:

PTO/SB/30 (07-09)
Approved for use through 07/31/2012. OMB 0651-0031
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.

Request

for

Continued Examination (RCE)

Transmittal

Address to:
Mail Stop RCE
Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450

Application Number
Filing Date
First Named Inventor
Art Unit
Examiner Name
Attorney Docket Number

This is a Request for Continued Examination (RCE) under 37 CFR 1.114 of the above-identified application.

Request for Continued Examination (RCE) practice under 37 CFR 1.114 does not apply to any utility or plant application filed prior to June 8,
1995, or to any design application. See Instruction Sheet for RCEs (not to be submitted to the USPTO) on page 2.

1.

Submission required under 37 CFR 1.114 Note: If the RCE is proper, any previously filed unentered amendments and
amendments enclosed with the RCE will be entered in the order in which they were filed unless applicant instructs otherwise. If
applicant does not wish to have any previously filed unentered amendment(s) entered, applicant must request non-entry of such
amendment(s).
Previously submitted. If a final Office action is outstanding, any amendments filed after the final Office action may be
considered as a submission even if this box is not checked.

a.
i.
Ii.
b.

2.

Other

________________

_____________________________________________________________

Enclosed
I.

Amendment/Reply

iii.

Information Disclosure Statement (IDS)

ii.

Affidavit(s)/ Declaration(s)

iv.

Other ______________________________

Miscellaneous
Suspension of action on the above-identified application is requested under 37 CFR 1.103(c) for a
period of ________ months. (Period of suspension shall not exceed 3 months; Fee under 37 CFR 1.17(i) required)
Other ____________________________________________________

a.
b.

3.

Consider the arguments in the Appeal Brief or Reply Brief previously filed on

Fees
a.

The RCE fee under 37 CFR 1.17(e) is required by 37 CFR 1.114 when the RCE is filed.
The Director is hereby authorized to charge the following fees, any underpayment of fees, or credit any overpayments, to
Deposit Account No. ____________________.

i.

RCE fee required under 37 CFR 1.17(e)

ii.

Extension of time fee (37 CFR 1.136 and 1.17)

iii.

Other ___________________________________________________________________________________

b.

Check in the amount of $ __________________________________enclosed

c.

Payment by credit card (Form PTO-2038 enclosed)

WARNING: Information on this form may become public. Credit card information should not be included on this form. Provide credit
card information and authorization on PTO-2038.
Signature
Name (Print/Type)

SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED
Date
Registration No.
CERTIFICATE OF MAILING OR TRANSMISSION

I hereby certify that this correspondence is being deposited with the United States Postal Service with sufficient postage as first class mail in an envelope
addressed to: Mail Stop RCE, Commissioner for Patents, P. O. Box 1450, Alexandria, VA 22313-1450 or facsimile transmitted to the U.S. Patent and Trademark
Office on the date shown below.
Signature
Name (Print/Type)

Date

This collection of information is required by 37 CFR 1.114. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Depa rtment of Commerce, P.O. Box 1450, Ale xandria, VA 22313-1450. DO NOT SE ND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO: Mail Stop RCE, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.

If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.

PTO/SB/30 (07-09)
Approved for use through 07/31/2012. OMB 0651-0031
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.

Instruction Sheet for RCEs
(not to be submitted to the USPTO)

NOTES:
An RCE is not a new application, and filing an RCE will not result in an application being accorded a new filing
date.
Filing Qualifications:

The appli cation must be a utility or plant application f iled on or after June 8, 1995. The app lication c annot be a provisional
application, a utility or plant application filed before J une 8, 1995, a design application, or a patent under reexamination. See
37 CFR 1.114(e).
Filing Requirements:
Prosecution in the application must be closed. Prosecution is closed if the applicat ion is under appeal, or the last Office
action is a final action, a notice of allowance, or an action that otherwise closes prosecution in the application (e.g., an Office
action under Ex parte Quayle). See 37 CFR 1.114(b).
A submission and a fee are required at the time the RCE is filed. If reply to an Office action under 35 U.S.C. 132 is
outstanding (e.g., the application is under final rejection), the submission must meet the reply requirements of 37 CFR 1.111. If
there is no outstanding Office action, the submission can be an information disclosure statement, an amendment, new
arguments, or new evidence. See 37 CFR 1.114(c). The submission may be a previously filed amendment ( e.g., an
amendment after final rejection).

WARNINGS:
Request for Suspension of Action:
All RCE filing requirements m ust be met before suspension of action is granted. A request for a suspension of
action under 37 C FR 1.103(c) does not satisfy the submission requirement and does not permit the filing of the
required submission to be suspended.
Improper RCE will NOT toll Any Time Period:
Before Appeal - If the RCE is improper (e.g., prosecution in the application is not c losed or the subm ission or
fee has not been filed) and the application is not under appeal, the time period set f orth in the last Off ice action
will continue to run and the application will be abandoned after the statutory time period has expired if a reply to
the Office action is not timely filed. No additional time will be given to correct the improper RCE.
Under Appeal - If the RCE is improper (e.g., the submission or the fee has not been filed) and the application is
under appeal, the improper RCE is effective to withdraw the appeal. Withdrawal of the appeal results in the
allowance or abandonment of the application depending on the status of the clai ms. If there are no allowed
claims, the application is abandoned. If there is at least one allowed claim, the application will be passed to issue
on the allowed claim(s). See MPEP 1215.01.

See MPEP 706.07(h) for further information on the RCE practice.

Page 2 of 2

Privacy Act Statement
The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.